![Nancy Whiting](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Nancy Whiting
Director/Board Member at
CARIBOU BIOSCIENCES, INC.
Net worth: - $ as of 30/05/2026
Profile
Nancy C.
Whiting is Co-President, Chief Executive Officer & Director at Recludix Pharma, Inc. starting in 2026.
Nancy is an Independent Director at Caribou Biosciences, Inc. since 2021 and at Boundless Bio, Inc. since 2023.
Former roles include President, Secretary & Director at Cascadian Therapeutics LLC and Executive VP-Strategy, Alliances & Communications at Seagen, Inc. from 2007 to 2021.
Education includes a doctorate from the University of Washington and an undergraduate degree from the University of British Columbia.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 19/04/2026 | 0 ( -.--% ) | - $ | 30/05/2026 | |
BOUNDLESS BIO INC. -.--% | 14/06/2026 | 0 ( -.--% ) | - $ | 30/05/2026 |
Nancy Whiting active positions
| Companies | Position | Start |
|---|---|---|
| CARIBOU BIOSCIENCES, INC. | Director/Board Member | 23/08/2021 |
| BOUNDLESS BIO, INC. | Director/Board Member | 01/10/2023 |
Recludix Pharma, Inc.
 Recludix Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company which develops novel small molecule medicines for inflammatory and immune related diseases | Chief Executive Officer | 31/08/2021 |
Former positions of Nancy Whiting
| Companies | Position | End |
|---|---|---|
| SEAGEN INC. | Public Communications Contact | 31/08/2021 |
| CASCADIAN THERAPEUTICS INC (USA) | President | - |
Training of Nancy Whiting
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
36
1st degree connections
7
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Seagen, Inc.
 Seagen, Inc. Pharmaceuticals: MajorHealth Technology Develops monoclonal antibody-based therapeutic products for treatment of cancer and immunologic diseases | Health Technology |
Cascadian Therapeutics LLC
 Cascadian Therapeutics LLC Medical SpecialtiesHealth Technology Develops therapeutic products for the treatment of cancer | Health Technology |
Caribou Biosciences, Inc.
 Caribou Biosciences, Inc. BiotechnologyHealth Technology Develops technology-based solutions for cellular engineering and analysis | Health Technology |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of British Columbia
 University of British Columbia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Boundless Bio, Inc.
 Boundless Bio, Inc. BiotechnologyHealth Technology Operates as a clinical-stage oncology company that develops cancer therapeutics | Health Technology |
Recludix Pharma, Inc.
Recludix Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company which develops novel small molecule medicines for inflammatory and immune related diseases | Commercial Services |
- Stock Market
- Insiders
- Nancy Whiting
